StrainsforPains, Inc. operates as a health and wellness company that specializes in data technology that develops and sells CBD/THC products. The company empowers healthcare providers, patients, and dispensaries with access to an AI search engine app enabling users to compare various cannabis strains or brands and assess their effectiveness in treating illnesses, chronic conditions, and dietary needs. Its product line covers pain related to muscle, migraines, arthritis, menstrual, sleep, and digestive disorders. The company collaborate with hospitals and pain management centers; and strategic partnerships with leading scientific and research organizations. The company was incorporated in 1990 and is based in New York, New York.
0 transactions — 0 buys and 0 sales reported by StrainsforPains, Inc. executives.
0 institutional funds report a position on EBYH in their latest SEC quarterly filing.
Beyond raw data, we aggregate and score every smart money signal to give you a unique view.
8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.
Detection of clustered purchases or sales by several executives in the same stock.
Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.
NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.
Spot marked changes in search interest around the stocks being followed.
Create your watchlist and receive a brief of events affecting your tickers.
This public page only shows a preview. The full analysis of EBYH on the Kairos Insider dashboard includes:
Free signup · Pro €19/month or €190/year